Table 1: General characteristics of the study population.
Total Subjects |
rtCGM |
isCGM |
p-value (2-tailed)* |
|
N |
117 |
78 |
39 |
|
Male (n, %) |
57 (48.7%) |
41 (52.6%) |
16 (41%) |
0.24 |
Age at diagnosis (years) |
6.8 (3.4) |
5.9 (3.0) |
8.4 (3.5) |
< 0.001 |
Age at last visit (years) |
11.9 (3.4) |
11.0 (3.6) |
13.7 (1.9) |
< 0.001 |
Duration of diabetes (years) |
5.1 (3.7) |
5.1 (3.6) |
5.3 (3.9) |
0.76 |
Weight SDS |
0.67 (0.9) |
0.59 (0.9) |
0.82 (1.1) |
0.28 |
Height SDS |
0.49 (0.9) |
0.43 (0.9) |
0.62 (1.0) |
0.33 |
BMI SDS |
0.55 (1.0) |
0.49 (1.0) |
0.67 (1.0) |
0.39 |
% CGM Use (3 months) |
92.5 (7.9) |
94.5 (6.3) |
88.3 (9.0) |
< 0.001 |
HbA1c (mmol/mol) |
57.2 (11.7) |
54.7 (10.8) |
62.1 (12.1) |
0.002 |
HbA1C (%) |
7.38 (1.1%) |
7.16 (1.0%) |
7.83 (1.1%) |
0.002 |
3-month GMI (mmol/mol) |
59.0 (9.3) |
57.2 (8.5) |
62.7 (9.9) |
0.004 |
3-month GMI (%) |
7.55 (0.8%) |
7.38 (0.8%) |
7.89 (0.9%) |
0.004 |
Data are n (%) or mean (SD), *Independent T-test, BMI: Body Mass Index; SDS: Standard Deviation Score; CGM: Continuous Glucose Monitoring; rtCGM: real time CGM; isCGM: intermittently scanned CGM; HbA1C: Haemoglobin A1C; GMI: Glucose Management Index